🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

PEI STAR-Go™ is a ready-to-use aqueous formulation of our high performance PEI STAR™ transfection reagent, provided as a sterile-filtered solution bit.ly/3LNNZLr

Embrace the messiness! Hear how Matt Disney, Professor at the FLORIDA Scripps Institute, pioneered a new field in drug discovery: drugging RNAs with small molecules. Matt shares his story and love for the imperfection of science here: apple.co/3AEPpFL & spoti.fi/4dLIEAQ

Embrace the messiness! Listen now: apple.co/3AEPpFL or spoti.fi/4dLIEAQ

Bio-Techne’s stem cells and organoid solutions support Jens Puschhof's research at DKFZ German Cancer Research Center. Is your research next? Learn more about our Stem Cells and Organoid solutions (bit.ly/3Z6ud5S)! #stemcell #organoid #cultrex #tissueengineer #regenmed

"All Great Truths Begin as Blasphemies” a quote from George Bernard Shaw that inspired BotN guest Jennifer Petter to take on the unimaginable task of finding small molecule therapeutics targeting RNA. 🎤 Listen now on: spoti.fi/4etUUpi or apple.co/47e3ar9!

Jennifer Petter is a biotech innovator and founder of Arrakis Therapeutics. Hear how she built a company on therapeutic opportunities for RNA targeting small molecules, and new treatments for cancer and more. Listen now: spoti.fi/3X23ggZ or apple.co/47e3ar9

Back of the Napkin discusses targeted protein degradation (TPD). Join Alessio Ciulli, Founder and Director at the Centre for Targeted Protein Degradation, on the secrets of TPD revolutionizing disease treatment. Listen now: apple.co/3BlrOKp or spoti.fi/4eyRBNw

A library of 240 compounds for your GPCR research, designed for HTS, HCS, target validation and assay development. #drugdiscovery #drugdevelopment #screening #compoundlibraries Learn More: bit.ly/4dxT1ax

Be inspired by Matt Disney, a Professor at the University of Florida Scripps Institute, who is comfortable being uncomfortable and a pioneer in drugging RNA with small molecules 🎙️#Sciencepodcast #biotech #RNA #Innovation Listen: apple.co/3AEPpFL & spoti.fi/4dLIEAQ

Listen to Back of the Napkin and hear Founder and Director of the Centre for Targeted Protein Degradation, Alessio Ciulli, recount the stories behind his key contributions to the field of targeted protein degradation. Listen now: spoti.fi/4d9jjj2 or apple.co/3BlrOKp

Amy Ripka, founder and CEO of Lucy Therapeutics joined us on the Back of the Napkin podcast. Hear how relentless curiosity led to pivotal breakthroughs in developing therapeutics for Parkinson's and Rett syndrome. Listen here: spoti.fi/4ef2uEy or apple.co/4eg6zII

Relentless curiosity is an ever-changing journey of ideation and innovation. Amy Ripka, the founder and CEO of Lucy Therapeutics, uses her curiosity to uncover therapeutics for Parkinson’s disease and Rett syndrome. Listen now: spoti.fi/3ZSLAHN or apple.co/4eg6zII

Jennifer Petter is passionate about RNA targeting with small molecules – and the promise it holds to treat various diseases. Listen in as she talks about being a biotech innovator and founder of Arrakis Therapeutics. Listen now: apple.co/47e3ar9 or spoti.fi/3X23ggZ

Spontaneously Blinking Janelia Fluor® Dyes, with duty cycle optimized for facile single-molecule localization microscopy (SMLM). bit.ly/3YpjZNa

Innovation comes to life when the lines blur between chemistry and biology. Chemist Neal Deveraj and his team at UC San Diego are finding success with artificial cells and bioorthogonal chemistry developments. Learn more: spoti.fi/3BycH0q or apple.co/4ewjlCT

Teamwork makes the dream work! Michelle Arkin, Professor at UC San Francisco and co-founder of Ambagon Therapeutics, is developing new ways to modulate protein-protein interactions. Listen now: apple.co/3ZWa6HX or spoti.fi/4dEOCSZ

A range of convenient and ready-to-use reagents in solution to save time on your stem cell culture and CGT workflows. Choose from CHIR 99021, LDN 193189, and ROCK inhibitor Y-27632 in 10 mM sterile-filtered solution. Learn more: bit.ly/4fcepmr

Discover our new far-red fluorescent transglutaminase-2 (TG2) probe for imaging endocytosis in vivo to explore targeted lysosomal degradation of secreted and cell surface proteins. Suitable for multiplexing and for use with confocal microscopy. bit.ly/40CsCnh

Cell-permeable fluorogenic fluorescent dyes used as self-labeling tag substrate for live-cell imaging. Exceptionally bright and photostable and suitable for confocal microscopy or super-resolution microscopy techniques including dSTORM. Learn more: bit.ly/4gCiWPP

MC3 LNP Luciferase is a fully formulated lipid nanoparticle (LNP) composed of DLin-MC3-DMA, DSPC, Cholesterol, DMG-PEG 2000, providing a benchmark LNP formulation. Contains a reporter luciferase mRNA for in vitro and in vivo bioluminescence detection. learn.bio-techne.com/3GMfg1t